Last week, readers were most interested in a story about QuidelOrtho's ongoing restructuring to support profitability.

The UK-based firm is developing its initial panel tests for Gram-negative bacteria with tests for Gram-positive bacteria and ...

The test will measure levels of the 14-3-3eta protein, which is used in the diagnosis and management of inflammatory diseases including rheumatoid arthritis.

The flow cytometry-based assay measures the expression of the protein FcyR11a as a biomarker for cardiovascular risk.

The Gram-positive blood culture assay is the firm's third panel for the detection and identification of bloodstream pathogens using the Liaison Plex instrument.

The firms said that the deal will provide access to Tempus' testing menu for healthcare providers at 800 cancer care locations that use Flatiron's OncoEMR platform.

Last week, readers were most interested in a story about Tempus' expectations for its acquisition of cancer testing firm Ambry.

NEW YORK – The US Food and Drug Administration in October granted 510(k) marketing clearances to molecular tests for infectious diseases, antimicrobial susceptibility tests, and a test for coagulation ...